Media releases are provided as is by companies and have not been edited or checked for accuracy. Any queries should be directed to the company itself.

ComOps Deploys Corporate Performance Reporting Solution For Healthcare Test Manufacturer

ComOps has secured a contract to deploy a corporate performance reporting solution for Enterix Australia.
  • 02 December, 2008 10:09

<p>Sydney, 2 December 2008 - ComOps, a leading Australian provider of business software products and services, has secured a contract to deploy a corporate performance reporting solution for Enterix, a wholly-owned subsidiary of Quest Diagnostics Incorporated. Enterix Australia manufactures the line of InSure® FIT fecal immunochemical tests sold in Australia and internationally as an aid in colorectal (bowel) cancer screening.</p>
<p>Enterix will deploy ComOps' modular Corporate Performance Reporting solution, including ComOps BI (business intelligence) for operational reports and analysis, ComOps Dashboard for management reports and KPI performance, and ComOps CRS (Corporate Reporting Services) for patient diagnosis report collation.</p>
<p>Following a review of several market solutions, ComOps was chosen for its ability to automate previously time-consuming processes and provide a single source of financial information from all parts of the Enterix business in Australia for reporting to Quest Diagnostics Incorporated, based in Madison, New Jersey, U.S.</p>
<p>“We chose ComOps following a careful review that included assessing recommendations from other organisations,” said Judy Readman, General Manager, Enterix. “While the proposed solution includes the reporting and dashboard features we require of a cost-effective reporting platform, we also selected ComOps based on their ability to respond rapidly and flexibly in meeting our specific requirements.”</p>
<p>ComOps will integrate with Enterix’s existing Patient Database system with a customised front end to enable Enterix to report and provide analytics on standard business processes, including revenue, product sales by category, and other information.</p>
<p>Enterix expects to go live with the solution by the end of 2008.</p>
<p>About Enterix (Australia)</p>
<p>Enterix (Australia), a Quest Diagnostics Company, is a US and Australian-based biotechnology company founded in 1997. Enterix manufactures, markets, and distributes a leading-edge product for bowel cancer screening called InSure®, a fecal immunochemical test (FIT) that is a useful screening aid for detecting primarily lower gastrointestinal bleeding disorders that may be related to iron deficiency anemia, diverticulitis, ulcerative colitis, polyps, adenomas, colorectal cancers or other gastrointestinal lesions that can bleed. Health professionals recommend FIT tests for use in screening for bowel cancer or other sources of lower gastrointestinal bleeding. Enterix was acquired in August 2006 by Quest Diagnostics, and is a wholly owned subsidiary of Quest Diagnostics Incorporated. Additional information is available at:</p>
<p>About ComOps Limited</p>
<p>ComOps Limited has a 36 year history in the IT industry and listed on the ASX in 1999. The company develops, sells and supports software and service solutions in the ERP, Business Intelligence, Mobile Sales Force Automation, e-Commerce, Retail, Risk Management and Safety Compliance, Workforce Management and Human Capital Management markets. These solutions are used by a range of blue chip clients such as Toll Holdings, Coca-Cola, Berri, Golden Circle, Australia Post, Toshiba, Orica, Lexmark, Canon, Queensland Government, NSW Lotteries, Commonwealth Bank of Australia and AMP, to name just a few.</p>
<p>ComOps is a Microsoft Gold Partner, Progress Premier Partner, is ISO 9001:2000 Quality Accredited and Government Endorsed.</p>

Most Popular